The February issue of MM&M magazine spotlights Policymed.com blogger Tom Sullivan.
Continuing his “ongoing probe into conflicts of interest,” Senator Chuck Grassley this week sent letters to the American Medical Association, Alzheimer’s Association, the American Cancer Society and 30 other disease and medical advocacy organizations asking them to provide details about the amount of money that they and their directors receive from drug and device makers.
Read more, including Senator Grassley’s letter, in Thomas Sullivan’s Policy and Medicine Blog.
In one of her final acts as NJ Attorney General, Anne Milgram’s office has issued a new report, “Physician Compensation Arrangements,” recommending limitations to physician-industry relationships for state agencies that go above and beyond guidelines outlined by PhRMA and other organizations.
Coalition Statement – DTC Advertising:
Recent news coverage regarding a Harvard Medical School study showing correlation between Plavix price increases for Medicaid programs in 27 states and direct-to-consumer advertising costs is unfounded. As study authors concluded, DTC advertising was not associated with an increase in Plavix use above preexisting trends.
As expected, the Ad Tax is back on the table as part of the pending healthcare reform legislation. Jim Davidson, head of the Advertising Coalition, is recommending calls to U.S. Senators urging REJECTION of the medical advertising tax proposal of Senator Franken-MN and 2 cosponsors, Senators Whitehouse-RI and Brown-OH.
Coalition tells Senate committee that real patient interests trump potential “conflicts of interest” as nation expands access to care.
From DTC Perspectives:
Representatives John Fleming and Frank Pallone set Erin Burnett of CNBC straight on the value of DTC and why removing its tax deductibility is not a good idea.
Washington lobbyists working with the Advertising Coalition breathed a bit easier Friday when learning that the Ad Tax Provision was not likely to be in the House revenue options for funding healthcare reform. But watch the news carefully.